Free Trial

Jack Slevin Analyst Performance

Analyst at Jefferies Financial Group

Jack Slevin is a stock analyst at Jefferies Financial Group focused in the medical sector, covering 7 publicly traded companies. Over the past year, Jack Slevin has issued 7 stock ratings, including strong buy, buy, and hold recommendations. While full access to Jack Slevin's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Jack Slevin's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions.

Analyst Rankings, Coverage, and Performance Statistics

Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
8 Last 1 Years
Buy Recommendations
75.00% 6 Buy Ratings
Companies Covered
7 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy12.5%1 ratings
Buy62.5%5 ratings
Hold25.0%2 ratings
Sell0.0%0 ratings

Out of 8 total stock ratings issued by Jack Slevin at Jefferies Financial Group, the majority (62.5%) have been Buy recommendations, followed by 25.0% Hold and 12.5% Strong Buy.

Best & Worst Calls

This analyst does not have any ratings with enough history to determine best and worst calls.

Exchange Coverage

ExchangePercentageCount
NYSE
57.1% of companies on NYSE
4 companies
NASDAQ
42.9% of companies on NASDAQ
3 companies

Jack Slevin, an analyst at Jefferies Financial Group, currently covers 7 companies listed on NYSE and NASDAQ, with the majority traded on NYSE.

Coverage Focus

Sector IconSectorPercentage
Medical
5 companies
71.4%
Business Services
1 company
14.3%
Consumer Discretionary
1 company
14.3%

Jack Slevin of Jefferies Financial Group specializes in stock coverage within the Medical sector, with additional focus on Business Services and Consumer Discretionary companies.

Coverage Industries

IndustryPercentage
MEDICAL SERVICES
2 companies
28.6%
MED - OUTP/HM CRE
2 companies
28.6%
MEDICAL INFO SYS
1 company
14.3%
STAFFING
1 company
14.3%
SCHOOLS
1 company
14.3%

Jack Slevin's Ratings History at Jefferies Financial Group

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
CompanyReport DateActionReport Date Price12-Month
Price Target
Rating12-Month
Price & ROI
Details
Pediatrix Medical Group, Inc. stock logo
MD
Pediatrix Medical Group
4/20/2026Reiterated Rating$23.24$27.00Buy
U.S. Physical Therapy, Inc. stock logo
USPH
U.S. Physical Therapy
3/12/2026Upgrade$77.86Strong-Buy
U.S. Physical Therapy, Inc. stock logo
USPH
U.S. Physical Therapy
3/9/2026Initiated Coverage$80.72$102.00Buy
Privia Health Group, Inc. stock logo
PRVA
Privia Health Group
2/26/2026Reiterated Rating$24.91$32.00Buy
Cross Country Healthcare, Inc. stock logo
CCRN
Cross Country Healthcare
12/4/2025Set Price Target$7.44$8.65Hold
Astrana Health, Inc. stock logo
ASTH
Astrana Health
11/25/2025Lower Price Target$23.46$37.00Buy
Agilon Health, Inc. stock logo
AGL
Agilon Health
8/15/2025Lower Price Target$27.38$27.50Hold
Adtalem Global Education Inc. stock logo
ATGE
Adtalem Global Education
4/23/2025Initiated Coverage$102.27$135.00Buy